| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 2 Apr 2025 | 27 Mar 2025 |
| Dhampur Bio Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/04/2025 inter alia to consider and approve the Employee Stock Option Scheme in terms of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations 2021. outcome of Board Meeting held on April 02, 2025 (As Per Bse Announcement Dated on 02.04.2025) | ||
| Board Meeting | 4 Feb 2025 | 30 Jan 2025 |
| Dhampur Bio Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2025 inter alia to consider and approve 1. the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31 2024. 2. the Employee Stock Option Scheme in terms of SEBI (Share Based Employee Benefits and Sweat Equity) regulations 2021. Outcome of the Board Meeting held on Tuesday, February 04, 2025 interalia approving standalone and consolidated financial results for the quarter and nine months ended December 31, 2024. Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we wish to inform that the Board at its meeting held on Tuesday, February 04, 2025 approved the re-appointment of non-executive Independent Directors of the Company. (As Per BSE Announcement dated on 04.02.2025) | ||
| Board Meeting | 4 Nov 2024 | 28 Oct 2024 |
| Quarterly Results Pursuant to the provisions of the Regulations 33 and 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (herein after referred to as Listing Regulation), we wish to inform you that, the Board of Directors at its Meeting held today i.e. Monday, November 4, 2024, has inter-alia approved the following (As per BSE Announcement Dated on 04/11/2024) | ||
| Board Meeting | 25 Jul 2024 | 19 Jul 2024 |
| Dhampur Bio Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2024 inter alia to consider and approve the unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30 2024. Pursuant to Regulation 33 of SEBI (LODR) Regulation, 2015, we wish to intimate that the Board at its meeting held on July 25, 2024 has approved the financial results for the quarter ended June 30, 2024. Unaudited Financial Results for the quarter ended June 30, 2024 (As per BSE Announcement Dated on 25/07/2024) | ||
| Board Meeting | 24 Apr 2024 | 18 Apr 2024 |
| Dhampur Bio Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/04/2024 inter alia to consider and approve 1. The audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended on March 31 2024. 2. To recommend dividend if any on equity shares of the Company for the financial year 2023-24. 3. To fix date of 4th Annual General Meeting. The Board of Directors at its Meeting held today i.e. Wednesday, April 24, 2024, has inter-alia approved the following: i) Audited (Standalone and Consolidated) Financial Results for the quarter and year ended March 31, 2024. ii) Recommendation of payment of dividend of Rs. 2.50 per equity share of Rs. 10 each for the financial year ended on March 31, 2024 subject to approval of shareholders at the ensuing 4th Annual General Meeting. The record date for the purpose of payment of Dividend for the financial year ended on March 31, 2024 shall be June 28, 2024. iii) Proposal to convene and hold the 4th Annual General Meeting of the Shareholders of the Company on July 5, 2024. iv) Re-appointment of Mr. Sandeep Kumar (DIN: 06906510) as Whole Time Director for a period of 1 year w.e.f. May 05, 2024, subject to approval of shareholders of the Company at the ensuing AGM of the Company Audited Financial results for the quarter and year ended March 31, 2024 The Board at its meeting held on April 24, 2024 recommended the payment of dividend at the rate of Rs. 2.50 per equity shares, to the shareholders of the Company at the ensuing Annual General Meeting of the Company (As Per BSE Announcement dated on 24.04.2024) | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
